Kardiologische Praxis Wermsdorf

At Kardiologische Praxis Wermsdorf, investigators are concentrating on cardiovascular diseases, with a particular focus on Atherosclerotic Cardiovascular Disease. The studies aim to test innovative treatments that could lower the risk of serious heart, stroke, or vascular events.

• Evaluation of AZD0780 in reducing major adverse cardiac events
• Assessment of therapy impact on cardiovascular death, myocardial infarction and ischemic stroke
• Exploration of treatment benefits for patients at high cardiovascular risk

The site’s work seeks to improve outcomes for individuals with high‑risk heart conditions and to provide new options for preventing life‑threatening events.

Research at the Wermsdorf practice also addresses respiratory tract diseases, especially Chronic Obstructive Pulmonary Disease (COPD). Clinical trials are designed to compare advanced inhaled regimens and determine their effect on severe cardiopulmonary outcomes.

• Comparison of triple therapy (budesonide, glycopyrronium, formoterol) versus dual bronchodilator therapy
• Investigation of inhaled treatment safety on heart and lung health
• Measurement of exacerbation reduction and overall respiratory function

These studies aim to enhance disease management for COPD patients while also monitoring potential cardiovascular benefits.